Clough Capital Partners’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Clough Capital Partners’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-17,066	Closed	-$3.37M	–	132
2020 Q2	$3.37M	Sell	17,066 -4,280	-20%	-$886K	0.33%	80
2020 Q1	$4.18M	Buy	21,346 +2,280	+12%	+$491K	0.42%	52
2019 Q4	$3.94M	Sell	19,066 -12,757	-40%	-$2.36M	0.34%	67
2019 Q3	$4.86M	Sell	31,823 -32,150	-50%	-$5.27M	0.4%	53
2019 Q2	$8.25M	Buy	63,973 +51,120	+398%	+$6.06M	0.81%	48
2019 Q1	$1.51M	Sell	12,853 -13,250	-51%	-$1.34M	0.13%	86
2018 Q4	$2.4M	Buy	26,103 +5,550	+27%	+$563K	0.28%	78
2018 Q3	$2.31M	Sell	20,553 -30,700	-60%	-$3.24M	0.22%	76
2018 Q2	$4.72M	Buy	51,253 +1,300	+3%	+$126K	0.42%	66
2018 Q1	$4.98M	Sell	49,953 -16,500	-25%	-$1.78M	0.48%	61
2017 Q4	$6.23M	Sell	66,453 -6,000	-8%	-$568K	0.52%	56
2017 Q3	$7.37M	Buy	72,453 +2,600	+4%	+$227K	0.49%	55
2017 Q2	$5.34M	Sell	69,853 -5,017	-7%	-$422K	0.37%	64
2017 Q1	$6.45M	Buy	74,870 +57,700	+336%	+$4.16M	0.41%	65
2016 Q4	$1.1M	Sell	17,170 -31,000	-64%	-$1.91M	0.07%	119
2016 Q3	$3.12M	Sell	48,170 -16,800	-26%	-$947K	0.16%	114
2016 Q2	$3.6M	Buy	64,970 +11,000	+20%	+$553K	0.19%	116
2016 Q1	$2.26M	Sell	53,970 -71,830	-57%	-$3.33M	0.11%	133
2015 Q4	$7.91M	Buy	+125,800	New	+$6.43M	0.37%	82

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Clough Capital Partners's LKFT Position: Q3 2020 in Review

Clough Capital Partners sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 17,066 shares — an estimated $3.37M sold.

Clough Capital Partners first reported a position in LKFT in Q4 2015 and held it in 19 quarters. The position peaked at $8.25M in Q2 2019. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

Clough Capital Partners reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Clough Capital Partners sold 17,066 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $3.37M.
Clough Capital Partners first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2015 and held it in 19 quarters.
Clough Capital Partners's Lakefront Biotherapeutics American Depositary Shares position peaked at $8.25M in Q2 2019.
119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on Clough Capital Partners's 13F filing for Q3 2020, filed 17 Nov 2020.